A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus

BACKGROUND: With the available evidence of early combined oral drug therapies being more effective in lowering blood glucose levels than maximal doses of a single drug, many clinicians are taking the aggressive approach of adding a sulfonylurea or a dipeptidyl peptidase-4 (DPP-4) inhibitor to metfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tandon, Tanya, Dubey, Ashok K., Srivastava, Saurabh, Manocha, Sachin, Arora, Ekta, Hasan, Nazer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482796/
https://www.ncbi.nlm.nih.gov/pubmed/31041232
http://dx.doi.org/10.4103/jfmpc.jfmpc_22_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482796/
https://www.ncbi.nlm.nih.gov/pubmed/31041232
http://dx.doi.org/10.4103/jfmpc.jfmpc_22_19

Ejemplares similares